Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.

Brunn A, Nagel I, Montesinos-Rongen M, Klapper W, Vater I, Paulus W, Hans V, Blümcke I, Weis J, Siebert R, Deckert M.

Acta Neuropathol. 2013 Oct;126(4):603-5. doi: 10.1007/s00401-013-1169-7. Epub 2013 Sep 6. No abstract available.

PMID:
24061549
2.

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.

Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso J, Medeiros LJ, Yang DT, Nabhan C.

Cancer. 2016 Feb 15;122(4):559-64. doi: 10.1002/cncr.29781. Epub 2015 Nov 13.

PMID:
26565895
3.

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.

Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH, de Jong D, Maartense E, Schuuring E, Kluin PM.

Blood. 1998 Nov 1;92(9):3152-62.

4.

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.

Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, Sanger WG, Weisenburger DD.

Leuk Lymphoma. 2015;56(11):3082-9. doi: 10.3109/10428194.2015.1034699. Epub 2015 May 12.

PMID:
25827211
5.

Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.

Hattab EM, Martin SE, Al-Khatib SM, Kupsky WJ, Vance GH, Stohler RA, Czader M, Al-Abbadi MA.

Mod Pathol. 2010 Feb;23(2):235-43. doi: 10.1038/modpathol.2009.164. Epub 2009 Nov 20.

6.

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.

Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, Klapper W, Hummel M, Stein H, Hansmann ML, Schmelter C, Möller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trümper L, Siebert R, Loeffler M, Rosenwald A, Ott G; German High-Grade Non-Hodgkin Lymphoma Study Group.

Blood. 2013 Mar 21;121(12):2253-63. doi: 10.1182/blood-2012-06-435842. Epub 2013 Jan 18.

7.

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.

Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.

PMID:
23348205
8.

Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.

Lima FP, Bousquet M, Gomez-Brouchet A, de Paiva GR, Amstalden EM, Soares FA, Dastugue N, Vassallo J, Brousset P.

Am J Clin Pathol. 2008 May;129(5):723-6. doi: 10.1309/CMPGPYTMFRM6RVQR.

9.

Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?

Mationg-Kalaw E, Tan LH, Tay K, Lim ST, Tang T, Lee YY, Tan SY.

Histopathology. 2012 Dec;61(6):1214-8. doi: 10.1111/j.1365-2559.2012.04351.x. Epub 2012 Nov 21.

PMID:
23171357
10.

Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Borovecki A, Korać P, Nola M, Ivanković D, Jaksić B, Dominis M.

Croat Med J. 2008 Oct;49(5):625-35.

11.

Composite diffuse large B-cell lymphoma and precursor B lymphoblastic lymphoma presenting as a double-hit lymphoma with MYC and BCL2 translocation.

Nanua S, Bartlett NL, Hassan A, Robirds D, Branson J, Frater JL, Nguyen TT, Kreisel F.

J Clin Pathol. 2011 Nov;64(11):1032-4. doi: 10.1136/jclinpath-2011-200143. Epub 2011 Jul 21. No abstract available.

PMID:
21778297
12.

ID3 mutations are recurrent events in double-hit B-cell lymphomas.

Gebauer N, Bernard V, Feller AC, Merz H.

Anticancer Res. 2013 Nov;33(11):4771-8.

PMID:
24222112
13.

Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.

Kobayashi T, Tsutsumi Y, Sakamoto N, Nagoshi H, Yamamoto-Sugitani M, Shimura Y, Mizutani S, Matsumoto Y, Nishida K, Horiike S, Asano N, Nakamura S, Kuroda J, Taniwaki M.

Jpn J Clin Oncol. 2012 Nov;42(11):1035-42. doi: 10.1093/jjco/hys148. Epub 2012 Sep 14.

14.

Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.

Durnick DK, Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, McPhail ED.

Am J Clin Pathol. 2010 Aug;134(2):278-81. doi: 10.1309/AJCPATUP1D0HGCUG.

15.
16.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

17.

A clinician's guide to double hit lymphomas.

Cheah CY, Oki Y, Westin JR, Turturro F.

Br J Haematol. 2015 Mar;168(6):784-95. doi: 10.1111/bjh.13276. Epub 2014 Dec 22. Review.

PMID:
25529575
18.

MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.

Tapia G, Baptista MJ, Muñoz-Marmol AM, Gaafar A, Puente-Pomposo M, Garcia O, Marginet-Flinch R, Sanz C, Navarro JT, Sancho JM, Ribera JM, Ariza A, Mate JL.

APMIS. 2015 Jul;123(7):596-603. doi: 10.1111/apm.12390. Epub 2015 May 22.

PMID:
26010683
19.

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.

McCluggage WG, Catherwood M, Alexander HD, McBride HA, Smith ME, Morris TC.

Histopathology. 2002 Nov;41(5):414-20.

PMID:
12405909
20.

Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.

Gualco G, Weiss LM, Harrington WJ Jr, Bacchi CE.

Am J Surg Pathol. 2009 Dec;33(12):1815-22. doi: 10.1097/PAS.0b013e3181bb9a18.

Items per page

Supplemental Content

Write to the Help Desk